C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2011
09/06/2011	US8013112 Compositions comprising human brain natriuretic peptide (BNP) fragments
09/06/2011	US8012938 Proteins of the "uncoupling proteins" family, with another active agent; obesity, diabetes, hyperlipidemia
09/06/2011	US8012935 Oligopeptide for blocking cancer
09/06/2011	US8012934 Small peptides and methods for treatment of inflammation
09/06/2011	US8012710 Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders
09/06/2011	US8012707 MN gene and protein
09/06/2011	US8012700 Assays for preimplantation factor and preimplantation factor peptides
09/01/2011	WO2011105648A1 Oligopeptide improving differentiation of osteoblasts
09/01/2011	WO2011104627A1 Metabolites of dop2-d-lys(dop2)-cyclo[cys-tyr-d-trp-lys-abu-cys]-thr-nh2
09/01/2011	WO2011103668A1 Cancer specific peptides and arrays for screening same
09/01/2011	WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses
09/01/2011	WO2011036445A3 Polypeptides and uses thereof
09/01/2011	US20110213293 Ligands to radiation-induced molecules
09/01/2011	US20110213124 Methods and systems for synthesis of a d-aminoluciferin precursor and related compounds
09/01/2011	US20110213123 Compositions and methods for modification of biomolecules
09/01/2011	US20110213082 Insulinotropic peptide synthesis using solid and solution phase combination techniques
09/01/2011	US20110212896 Peptides for the treatment of oxidative stress related disorders
09/01/2011	US20110212890 Metastin derivative and use thereof
09/01/2011	US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/01/2011	US20110212470 Biomarkers for rheumatoid arthritis
09/01/2011	US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions
09/01/2011	US20110212116 Immunogenic peptides and uses thereof
09/01/2011	US20110212115 Melk epitope peptides and vaccines containing the same
09/01/2011	US20110212105 Method to block the infection by flaviviruses, molecules and uses
09/01/2011	US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof
09/01/2011	US20110212095 Epitope of cd66c specific to lung adenocarcinoma and antibody recognizing the same
09/01/2011	US20110212075 Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders
09/01/2011	US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof
09/01/2011	US20110212028 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
09/01/2011	CA2790818A1 Modulation of cytokine-induced chronic inflammatory responses
08/2011
08/31/2011	EP2361925A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/31/2011	EP2361258A1 A nonapeptide with anti-tumour activity
08/31/2011	CN102171340A MELK epitope peptides and vaccines containing the same
08/31/2011	CN102171240A Methods of treating inflammation
08/31/2011	CN102171239A Peptides and compositions for prevention of cell adhesion and methods of using same
08/31/2011	CN102170899A Peptide sequences, their branched form and use thereof for antimicrobial applications
08/31/2011	CN102170897A Vaccine containing amb a 1 for treating allergy to ragweed
08/31/2011	CN102167731A Method for preparing omiganan through solid phase peptide synthesis
08/31/2011	CN102167730A Conotoxin analog Glu-Con-G[1-13], and design and synthesis method and application thereof
08/31/2011	CN102167729A Conotoxin analog Glu-Con-G (Glutamate-Conantokin-G) with morphine-dependent resistance and analgesic effect
08/31/2011	CN102167728A Improved gastrin releasing peptide compounds
08/31/2011	CN102167723A Preparation method of polypeptide synthesis carbetocin
08/31/2011	CN101597578B Enramycin producing strain and extraction method by using macroporous resin
08/31/2011	CN101492495B A group of antigen epitope polypeptide and uses thereof
08/30/2011	US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
08/30/2011	US8008431 Tumor-associated peptides that bind to MHC-molecules
08/30/2011	US8008260 Methods of protecting against apoptosis using lipopeptides
08/30/2011	US8008250 Macrocyclic compounds and compositions useful as BACE inhibitors
08/30/2011	US8007770 Purified linear polypeptide epitopes from walnuts and associated methods
08/30/2011	CA2361534C Alpha-conotoxin peptides
08/30/2011	CA2283630C Ligand/lytic peptide compositions and methods of use
08/25/2011	WO2011103311A2 Treatments for gastrointestinal disorders
08/25/2011	WO2011103011A2 Gene fusion targeted therapy
08/25/2011	WO2011101510A1 Cyclic peptides that inhibit cell growth
08/25/2011	WO2011071280A9 Intracelluar targeting bipodal peptide binder
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207678 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
08/25/2011	US20110207674 Antitumoral compounds
08/25/2011	US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof
08/25/2011	US20110207658 High Purity Lipopeptides
08/25/2011	US20110207657 Selectively Targeted Antimicrobial Peptides and the Use Thereof
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206713 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
08/25/2011	US20110206711 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine employing same
08/25/2011	US20110206709 T-cell antigen peptide from allergen for stimulation of il-10 production
08/25/2011	US20110206674 Yersinia SPP. Polypeptides and Methods of Use
08/25/2011	US20110206637 Antiviral agents
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	CA2790213A1 Treatments for gastrointestinal disorders
08/24/2011	EP2360180A2 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
08/24/2011	EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor
08/24/2011	EP2358740A1 Cyclic peptides and uses thereof
08/24/2011	EP2358739A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
08/24/2011	EP2358738A2 Modulators of the cx3cr1 receptor and therapeutic uses thereof
08/24/2011	EP2358737A2 Rgd-containing peptidomimetics and uses thereof
08/24/2011	EP1369426B1 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
08/24/2011	CN102164948A Nonimmunosuppressive cyclosporine analogue molecules
08/24/2011	CN102164947A Peptide compound and method for producing same
08/24/2011	CN102164944A Method for processing microbiologically produced cyclic oligopeptides
08/24/2011	CN102160890A Pharmaceutical composition comprising an analgesic peptide
08/23/2011	US8003756 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
08/23/2011	US8003753 Fret protease assays for clostridial toxins
08/23/2011	US8003613 Methods and compositions for inducing apoptosis
08/23/2011	US8003610 Bradykinin B2 receptor antagonist peptide from amphibian skin
08/23/2011	US8003609 Method for ameliorating pain by modification of NMDA receptors through inhibition of Src
08/23/2011	US8003595 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
08/23/2011	CA2377209C Therapeutic peptide-based constructs
08/23/2011	CA2335488C Conformationally constrained backbone cyclized somatostatin analogs
08/23/2011	CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
08/23/2011	CA1341620C Envelope antigens of hiv-1
08/18/2011	WO2011098095A1 Peptides binding the tpo receptor
08/18/2011	WO2011049956A3 Toxicity-associated genes, genetic variants, and use thereof
08/18/2011	WO2011038142A3 Bladder cancer specific ligand peptides
08/18/2011	US20110201987 Combination therapy for preventing or treating alzheimer's disease, and kit therefor
08/18/2011	US20110201560 Peptides for inhibiting the hpv-e6 oncoprotein
08/18/2011	US20110201559 New Optically Pure Compounds for Improved Therapeutic Efficiency
08/18/2011	US20110201544 Compositions and Methods for Inhibiting the Interaction between CFTR and CAL
08/18/2011	US20110201541 Tissue occluding agent
08/18/2011	US20110201518 Healthy kidney biomarkers

1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 423